<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93936">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01712555</url>
  </required_header>
  <id_info>
    <org_study_id>New York Eye and Ear Infirmary</org_study_id>
    <nct_id>NCT01712555</nct_id>
  </id_info>
  <brief_title>Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets</brief_title>
  <official_title>Autologous Fat Grafting to Anophthalmic Sockets With PRP (Platelet Rich Plasma) Using a Closed Cannula Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fox, Donald Munro, M.D., P.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fox, Donald Munro, M.D., P.C.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After people lose an eye, for whatever reason, they often experience fat atrophy of the
      tissues in the orbit. This leads to a sunken appearance that is often not correctable by a
      cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/
      invasive.  Injection of various gels (Restylane, Radiesse) are temporary had have their own
      disadvantages.  This study seeks to demonstrate an improvement in the retention of injected
      autologous fat by mixing in autologous PRP (platelet rich plasma).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Improved retention of autologous fat injected into anophthalmic sockets</measure>
    <time_frame>1-5 yrs</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Non contrast MRIs of the orbits are obtained  before, immediately after, and one year after injection of autologous fat mixed with autologous PRP (platelet rich plasma)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Orbital Atrophy</condition>
  <arm_group>
    <arm_group_label>autologous fat grafting with PRP to anophthalmic orbits</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There is only one arm to this study.  People with orbital atrophy and loss of an eye are to be injected with autologous fat mixed with autologous PRP (platelet rich plasma) and observed for one year for evidence of retention of the injected fat</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autologous fat grafting with PRP to anophthalmic orbits</intervention_name>
    <arm_group_label>autologous fat grafting with PRP to anophthalmic orbits</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: anophthalmos, orbital atrophy -

        Exclusion Criteria:poor anesthesia risk, people outside a 100 mile radius of New York City

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Donald M Fox, MD</last_name>
    <phone>(212) 772-1500</phone>
    <email>dmfmdjr@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York Eye and Ear Infirmary</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald M Fox, MD</last_name>
      <phone>212-772-1500</phone>
      <email>dmfmdjr@Yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Donald M Fox, MD</last_name>
      <phone>212 772-1500</phone>
      <email>dmfmdjr@Yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Donald M Fox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Eye and Ear Infirmary</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald Fox, MD</last_name>
      <phone>212-772-1500</phone>
      <email>dmfmdjr@Yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Donald Fox, MD</last_name>
      <email>dmfmdjr@Yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Donald M Fox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.newyorkfami.com</url>
    <description>related info</description>
  </link>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 23, 2014</lastchanged_date>
  <firstreceived_date>October 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anophthalmic orbits</keyword>
  <keyword>autologous fat</keyword>
  <keyword>platelet rich plasma</keyword>
  <keyword>orbital atrophy</keyword>
  <keyword>anophthalmos</keyword>
  <keyword>cannula</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
